The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Vascularized cancer on a chip: The effect of perfusion on growth and drug delivery of tumor spheroid
Open accessAbstract
Tumor vasculature creates a hostile tumor microenvironment (TME) in vivo and nourishes cancers, resulting in cancer progression and drug resistance. To mimic the biochemical and biomechanical environments of tumors in vitro, several models integrated with a vascular network have been reported. However, the tumor responses to biochemical and biomechanical stimuli were evaluated under static conditions and failed to incorporate the effects of blood flow to tumors. In this study, we present a tumor-on-a-chip platform that enables the evaluation of tumor activities with intraluminal flow in an engineered tumor vascular network. The fibroblasts in the tumor spheroid induced angiogenic sprouts, which constructed a perfusable vascular network in a tumor spheroid. The perfusability of the engineered vascular network was preserved during the culture. Moreover, perfusion for over 24 h significantly increased the proliferation activities of tumor cells and decreased cell death in the spheroid. Drug administration under perfusion condition did not show the dose-dependent effects of anticancer drugs on tumor activities in contrast to the results under static conditions. Our results demonstrate the importance of flow in a vascular network for the evaluation of tumor activities in a drug screening platform.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the vascularization of tumoroids can be maintained for 22 days.”
From 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor‐on‐a‐Chip (2023) · cites this paper as [104]
In the citing paper
“Sprouting from the endothelial layer in the side channels into the middle compartment containing a tumor spheroid was triggered by the presence of fibroblasts in the spheroids [58].”
From Cancer-on-chip models for metastasis: importance of the tumor microenvironment (2024) · cites this paper as [58]
Citations
Cites
Organogenesis in a dish: Modeling development and disease using organoid technologies
Lancaster, M. A., & Knoblich, J. A. (2014) · Science · doi:10.1126/science.1247125 · Cited by 2,931
Influence of tumour micro-environment heterogeneity on therapeutic response
Junttila, M. R., & de Sauvage, F. J. (2013) · Nature · doi:10.1038/nature12626 · Cited by 2,694
Cell and environment interactions in tumor microregions: the multicell spheroid model.
Sutherland, R. M. (1988) · Science · doi:10.1126/science.2451290 · Cited by 1,803
Spheroid-based drug screen: Considerations and practical approach
Friedrich, J., Seidel, C., Ebner, R., & Kunz-Schughart, L. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.226 · Cited by 1,742
Role of tumor microenvironment in tumorigenesis
Wang, M., Zhao, J., Zhang, L., Wei, F., Lian, Y., Wu, Y., Gong, Z., Zhang, S., Zhou, J., Cao, K., et al. (2017) · Journal of Cancer · doi:10.7150/jca.17648 · Cited by 1,404
Cell surface mechanics and the control of cell shape, tissue patterns and morphogenesis
Lecuit, T., & Lenne, P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2222 · Cited by 1,326
Abbott, A. (2003) · Nature · doi:10.1038/424870a · Cited by 1,228
Spherical Cancer Models in Tumor Biology
Weiswald, L., Bellet, D. H., & Dangles‐Marie, V. (2015) · Neoplasia · doi:10.1016/j.neo.2014.12.004 · Cited by 1,194
Reconstruction of Tissues by Dissociated Cells
Steinberg, M. S. (1963) · Science · doi:10.1126/science.141.3579.401 · Cited by 1,127
The Role of Mechanical Forces in Tumor Growth and Therapy
Jain, R. K., Martin, J. D., & Stylianopoulos, T. (2014) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071813-105259 · Cited by 1,044
Lost in translation: animal models and clinical trials in cancer treatment.
(2014) · Europe PMC (PubMed Central) · Cited by 1,033
Three-dimensional culture systems in cancer research: Focus on tumor spheroid model
Nath, S., & Devi, G. R. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.03.013 · Cited by 919
Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer
IMAMURA, Y., MUKOHARA, T., SHIMONO, Y., FUNAKOSHI, Y., CHAYAHARA, N., TOYODA, M., KIYOTA, N., TAKAO, S., KONO, S., NAKATSURA, T., et al. (2015) · Oncology Reports · doi:10.3892/or.2015.3767 · Cited by 845
Three-dimensional organotypic culture: experimental models of mammalian biology and disease
Shamir, E. R., & Ewald, A. J. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3873 · Cited by 719
Growth of Multicell Spheroids in Tissue Culture as a Model of Nodular Carcinomas 2
Sutherland, R. M., McCredie, J. A., & Inch, W. R. (1971) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/46.1.113 · Cited by 585
Butler, J. M., Kobayashi, H., & Rafii, S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2791 · Cited by 578
Cell migration into scaffolds under co-culture conditions in a microfluidic platform
Chung, S. H., Sudo, R., Mack, P. J., Wan, C.-R., Vickerman, V., & Kamm, R. D. (2008) · Lab on a Chip · doi:10.1039/b807585a · Cited by 530
Fluid forces control endothelial sprouting
Song, J. W., & Munn, L. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105316108 · Cited by 498
Yuan, F., Salehi, H. A., Boucher, Y., Vasthare, U. S., Tuma, R. F., & Jain, R. K. (1994) · PubMed · Cited by 463
3D microtumors in vitro supported by perfused vascular networks
Sobrino, A., Phan, D. T. T., Datta, R., Wang, X., Hachey, S. J., Romero-López, M., Gratton, E., Lee, A. P., George, S. C., & Hughes, C. C. W. (2016) · Scientific Reports · doi:10.1038/srep31589 · Cited by 387
Shirure, V. S., Bi, Y., Curtis, M. B., Lezia, A., Goedegebuure, M. M., Goedegebuure, S. P., Aft, R., Fields, R. C., & George, S. C. (2018) · Lab on a Chip · doi:10.1039/c8lc00596f · Cited by 316
The State of Innovation in Drug Development
Kola, I. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100479 · Cited by 276
Integrating perfusable vascular networks with a three-dimensional tissue in a microfluidic device
Nashimoto, Y., Hayashi, T., Kunita, I., Nakamasu, A., Torisawa, Y.-S., Nakayama, M., Takigawa-Imamura, H., Kotera, H., Nishiyama, K., Miura, T., et al. (2017) · Integrative Biology · doi:10.1039/c7ib00024c · Cited by 266
Self-citationKim, S., Chung, M., Ahn, J., Lee, S., & Jeon, N. L. (2016) · Lab on a Chip · doi:10.1039/c6lc00910g · Cited by 227
Simultaneous measurement of RBC velocity, flux, hematocrit and shear rate in vascular networks
Kamoun, W. S., Chae, S., Lacorre, D. A., Tyrrell, J. A., Mitre, M., Gillissen, M. A., Fukumura, D., Jain, R. K., & Munn, L. L. (2010) · Nature Methods · doi:10.1038/nmeth.1475 · Cited by 214
A three-dimensional in vitro model of tumor cell intravasation
Ehsan, S. M., Welch-Reardon, K. M., Waterman, M. L., Hughes, C. C. W., & George, S. C. (2014) · Integrative Biology · doi:10.1039/c3ib40170g · Cited by 196
Emerging tumor spheroids technologies for 3D in vitro cancer modeling
Rodrigues, T., Kundu, B., Silva-Correia, J., Kundu, S. C., Oliveira, J. M., Reis, R. L., & Correlo, V. M. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.10.018 · Cited by 178
Hanging-drop multicellular spheroids as a model of tumour angiogenesis
Timmins, N., Dietmair, S., & Nielsen, L. K. (2004) · Angiogenesis · doi:10.1007/s10456-004-8911-7 · Cited by 177
The Role of the Tumor Microenvironment in Regulating AngiogenesisPreprint
Watnick, R. S. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006676 · Cited by 162
Media additives to promote spheroid circularity and compactness in hanging drop platform
Leung, B. M., Lesher‐Pérez, S. C., Matsuoka, T., Moraes, C., & Takayama, S. (2014) · Biomaterials Science · doi:10.1039/c4bm00319e · Cited by 140
Tumor cells and their crosstalk with endothelial cells in 3D spheroids
Shoval, H., Karsch-Bluman, A., Brill-Karniely, Y., Stern, T., Zamir, G., Hubert, A., & Benny, O. (2017) · Scientific Reports · doi:10.1038/s41598-017-10699-y · Cited by 138
Biomimetic Model of Tumor Microenvironment on Microfluidic Platform
Chung, M., Ahn, J., Son, K., Kim, S., & Jeon, N. L. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700196 · Cited by 126
Howes, A. L., Richardson, R. D., Finlay, D., & Vuori, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108283 · Cited by 121
Flow perfusion effects on three-dimensional culture and drug sensitivity of Ewing sarcoma
Santoro, M., Lamhamedi-Cherradi, S.-E., Menegaz, B. A., Ludwig, J. A., & Mikos, A. G. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1506684112 · Cited by 107
A microfluidic platform for chemoresistive testing of multicellular pleural cancer spheroids
Ruppen, J., Cortes-Dericks, L., Marconi, E., Karoubi, G., Schmid, R. A., Peng, R., Marti, T. M., & Guenat, O. T. (2014) · Lab Chip · doi:10.1039/c3lc51093j · Cited by 105
Contributions of 3D Cell Cultures for Cancer Research
Ravi, M., Ramesh, A., & Pattabhi, A. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25664 · Cited by 90
Lamichhane, S. P., Arya, N., Kohler, E., Xiang, S., Christensen, J., & Shastri, V. P. (2016) · BMC Cancer · doi:10.1186/s12885-016-2634-1 · Cited by 79
Klimkiewicz, K., Weglarczyk, K., Collet, G., Paprocka, M., Guichard, A., Sarna, M., Jozkowicz, A., Dulak, J., Sarna, T., Grillon, C., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.03.006 · Cited by 70
Angiogenesis in Liquid Tumors: An In Vitro Assay for Leukemic‐Cell‐Induced Bone Marrow Angiogenesis
Zheng, Y., Sun, Y., Yu, X., Shao, Y., Zhang, P., Dai, G., & Fu, J. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201501007 · Cited by 50
Spheroids: relation between tumour and endothelial cells
Oudar, O. (2000) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00080-9 · Cited by 33
Cerino, G., Gaudiello, E., Muraro, M. G., Eckstein, F. S., Martín, I., Scherberich, A., & Marsano, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-13882-3 · Cited by 29
Biomimetic tumor-induced angiogenesis and anti-angiogenic therapy in a microfluidic model
Liu, L., Xie, Z., Zhang, W., Fang, S., Kong, J., Jin, D., Li, J., Li, X., Yang, X., Luo, Y., et al. (2016) · RSC Advances · doi:10.1039/c6ra05645h · Cited by 27
Perfusable Vascular Network with a Tissue Model in a Microfluidic Device
Nashimoto, Y., Teraoka, Y., Sadeghian, R. B., Nakamasu, A. M., Arima, Y., Hanada, S., Kotera, H., Nishiyama, K., Miura, T., & Yokokawa, R. (2018) · Journal of Visualized Experiments · doi:10.3791/57242 · Cited by 16
Cited by
Sorted by citations
A microfluidic platform integrating functional vascularized organoids-on-chip
Quintard, C., Tubbs, E., Jonsson, G., Jiao, J., Wang, J., Werschler, N., Laporte, C., Pitaval, A., Bah, T.-S., Pomeranz, G., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45710-4 · Cited by 387
Vascularized organoids on a chip: strategies for engineering organoids with functional vasculature
Zhang, S., Wan, Z., & Kamm, R. D. (2021) · Lab on a Chip · doi:10.1039/d0lc01186j · Cited by 331
Strategies to reduce the risks of mRNA drug and vaccine toxicity
Bitounis, D., Jacquinet, E., Rogers, M. A., & Amiji, M. M. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00859-3 · Cited by 242
Thorel, L., Perréard, M., Florent, R., Divoux, J., Coffy, S., Vincent, A., Gaggioli, C., Guasch, G., Gidrol, X., Weiswald, L.-B., et al. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01272-5 · Cited by 236
Microfluidics for Drug Development: From Synthesis to Evaluation
Liu, Y., Sun, L., Zhang, H., Shang, L., & Zhao, Y. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01289 · Cited by 211
Metadata
- Authors
- Nashimoto, Y., Okada, R., Hanada, S., Arima, Y., Nishiyama, K., Miura, T., & Yokokawa, R.
- Affiliations
- Tohoku University (JP)
- Kyoto University (JP)
- International Research Center for Medical Sciences, Kumamoto University (JP)
- Kyushu University (JP)
- Corresponding author
- Yokokawa, Ryuji
- ORCID
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2020-01
- Volume
- 229
- Pages
- 119547
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2981018318
- Cited by
- 332
- References
- 44
- Citations by year
- 2026: 36 · 2025: 46 · 2024: 66 · 2023: 59 · 2022: 58 · 2021: 39 · 2020: 28
- FWCI
- 10.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Biomaterials (acceptedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science
- Nakatomi Foundation
- Japan Science and Technology Agency
- Japan Agency for Medical Research and Development
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Keywords
- tumor-on-a-chip, tumor spheroids, perfusion, tumor vasculature, fibroblasts, tumor microenvironment, tumor cell proliferation, cell death, anticancer drug delivery, drug screening, blood flow
- MeSH terms
- Pharmaceutical Preparations, Humans, Neoplasms, Perfusion, Lab-On-A-Chip Devices, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review